ARCHIVES

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

This article is from The Cancer Letter archive.

Vol. 34 No. 25 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

Ohio State to study center expansion.

September 26, 2003

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says.

September 24, 2004